|
Market Closed -
NYSE
16:30:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 11.45 USD | -1.55% |
|
-0.17% | -22.37% |
| 08-31 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 1.4B | 96.55% | 96.55% | 46.46% | 42.02% | - | |
| 1.52B | 0.72% | 32.72% | 10.49% | 4.68% | - | |
| Average | 1.46B | 48.63% | 64.63% | 28.47% | 23.35% | ||
| Weighted average by Cap. | 1.46B | 49.55% | 65.24% | 28.82% | 23.71% |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Sector Daxor Corporation
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
